Detalhe da pesquisa
1.
Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study.
Gynecol Oncol
; 163(3): 598-604, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34649724
2.
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
Gynecol Oncol
; 158(3): 666-672, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32624235
3.
The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study.
Gynecol Oncol
; 157(1): 78-84, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32131977
4.
Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study.
Ann Oncol
; 30(5): 845-852, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30851097
5.
Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer.
Gynecol Oncol
; 155(2): 186-191, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31519320
6.
Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group.
Int J Gynecol Cancer
; 29(4): 691-698, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30772825
7.
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group.
Br J Cancer
; 116(3): 303-309, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28072765
8.
Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial.
Ann Oncol
; 28(8): 1842-1848, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28481967
9.
Networking for ovarian rare tumors: a significant breakthrough improving disease management.
Ann Oncol
; 28(6): 1274-1279, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28398524
10.
A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials.
Ann Oncol
; 26(2): 422-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25403589
11.
Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO.
Br J Cancer
; 108(9): 1771-7, 2013 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23612453
12.
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group.
Ann Oncol
; 24(4): 1099-104, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23139262
13.
Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study.
Ann Oncol
; 22(11): 2417-2423, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21402619
14.
Flexor tendon rupture after volar plating of distal radius fracture: A systematic review of the literature.
Hand Surg Rehabil
; 40(5): 535-546, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34033928
15.
A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery.
ESMO Open
; 6(4): 100209, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34325109
16.
Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience.
Ann Oncol
; 21(12): 2377-2381, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20494964
17.
The histone deacetylase inhibitor panobinostat is active in patients with advanced pretreated ovarian sex-cord tumors.
Ann Oncol
; 25(5): 1074-5, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24651409
18.
A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer.
Gynecol Oncol
; 108(1): 42-6, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17980406
19.
[Primary management of endometrial carcinoma. Joint recommendations of the French society of gynecologic oncology (SFOG) and of the French college of obstetricians and gynecologists (CNGOF)]. / Prise en charge primaire des cancers de l'endomètre : recommandations SFOG-CNGOF.
Gynecol Obstet Fertil Senol
; 45(12): 715-725, 2017 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-29132772
20.
[Laparoscopic interiliacal lymphadenectomy in cancer of the uterine cervix: still the gold standard? A propos lymph node recurrences in 190 treated patients]. / Lymphadénectomie inter-iliaque per-coelioscopique dans le cancer du col de l'utérus: toujours le gold standard? A propos des rechutes ganglionnaires après lymphadénectomie chez 190 patientes traitées.
J Gynecol Obstet Biol Reprod (Paris)
; 34(5): 473-80, 2005 Sep.
Artigo
em Francês
| MEDLINE | ID: mdl-16142138